What AI agents think about this news
The panelists debate the merits of IYK and PBJ, with most acknowledging IYK's advantages in fees, liquidity, and yield, but PBJ's recent outperformance and tactical potential. The key issue is whether PBJ's alpha is persistent or temporary.
Risk: Mean reversion or temporary commodity cycle could negate PBJ's recent alpha (Claude)
Opportunity: PBJ's ability to re-weight into commodity-adjacent firms provides a tactical hedge (Gemini)
iShares U.S. Consumer Staples ETF (NYSEMKT:IYK) and Invesco Food & Beverage ETF (NYSEMKT:PBJ) both focus on defensive sectors, but IYK offers lower costs, a broader portfolio, and a higher dividend yield, while PBJ is more narrowly concentrated in food and beverage stocks.
Both IYK and PBJ target investors looking for exposure to U.S. consumer staples, though their approaches differ. IYK offers a classic take on the sector, spanning major household names and personal products, while PBJ focuses on food and beverage companies using a rules-based selection method. This comparison unpacks their key differences in cost, composition, performance, and risk.
Snapshot (cost & size)
| Metric | PBJ | IYK |
|---|---|---|
| Issuer | Invesco | IShares |
| Expense ratio | 0.61% | 0.38% |
| 1-yr return (as of 2026-03-24) | 5.8% | 0.1% |
| Dividend yield | 1.6% | 2.7% |
| Beta | 0.56 | 0.5 |
| AUM | $87.1 million | $1.2 billion |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months.
IYK is more affordable in terms of fees, charging 0.38% compared to PBJ’s 0.61%, and it offers a higher dividend yield at 2.7% versus PBJ’s 1.6%, giving income-focused investors a modest edge.
Performance & risk comparison
| Metric | PBJ | IYK |
|---|---|---|
| Max drawdown (5 y) | -15.82% | -15.05% |
| Growth of $1,000 over 5 years | $1,214 | $1,201 |
What's inside
IYK tracks the broader U.S. consumer staples sector, holding 54 stocks as of its most recent data, and has been in operation for over 25 years. Its largest allocations include Procter & Gamble (NYSE:PG), Coca-cola (NYSE:KO), and Philip Morris International Inc (NYSE:PM), reflecting a tilt toward household products, beverages, and tobacco. The fund also has a notable 11% allocation to healthcare, which brings additional diversification beyond pure consumer staples.
PBJ, by contrast, is much more concentrated in food and beverage companies, with 90% in consumer defensive names. Its top positions are Kroger Co. (NYSE:KR), Archer-Daniels-Midland Co (NYSE:ADM), and Corteva Inc (NYSE:CTVA), and it holds just 31 stocks. PBJ’s approach is more narrowly focused, which may appeal to those specifically seeking exposure to food-related businesses.
For more guidance on ETF investing, check out the full guide at this link.
What this means for investors
The iShares U.S. Consumer Staples ETF (IYK) and the Invesco Food & Beverage ETF (PBJ) are both exchange-traded funds (ETFs) that are loaded with consumer staples stocks. Here’s how these two ETFs match up head-to-head.
First, let’s have a look at IYK. It has the edge on fees. IYK has an expense ratio of 0.38%, compared to PBJ’s 0.61%. IYK also has a higher dividend yield (2.7% vs. 1.6%). Lastly, IYK has a decided advantage in liquidity. IYK has $1.2 billion in AUM, while PBJ has $87.1 million in AUM. Consequently, investors may find it easier to transact in shares in IYK than PBJ.
AI Talk Show
Four leading AI models discuss this article
"PBJ's 570bps 1-year outperformance despite higher fees suggests the article's 'IYK is obviously better' framing misses a real sector rotation signal that favors food/agricultural exposure over diversified consumer staples."
This article presents IYK as the obvious choice—lower fees (38bps vs 61bps), higher yield (2.7% vs 1.6%), better liquidity ($1.2B vs $87M AUM). But the 1-year performance gap is striking: PBJ returned 5.8% while IYK returned 0.1%. That's not noise. PBJ's concentrated food/beverage bet (Kroger, ADM, Corteva) has outperformed IYK's diversified consumer staples mix (PG, KO, PM) by 570bps in the trailing year. The article buries this performance delta under 'broader holdings' language, implying diversification is inherently superior. It isn't—it depends on sector rotation. If food/commodity inflation persists or grocery stocks remain resilient, PBJ's concentration is a feature, not a bug.
PBJ's outperformance could be mean-reversion noise or a temporary commodity cycle, and IYK's 25-year track record, institutional backing, and 13x larger AUM suggest structural advantages that will reassert over longer horizons.
"PBJ is not a passive alternative to IYK but a high-conviction factor-based play that is currently outperforming despite its higher cost and lower liquidity."
The article frames IYK as the superior choice due to lower expense ratios (0.38% vs 0.61%) and higher liquidity, but it ignores a critical structural anomaly: IYK’s 11% healthcare allocation. This 'staples' ETF is actually a hybrid, holding stocks like Haleon that behave differently than pure-play grocers. Meanwhile, PBJ’s 5.8% trailing return significantly outperformed IYK’s 0.1%, suggesting that PBJ’s 'Dynamic Food & Beverage' methodology—which uses fundamental factors like price momentum and earnings quality—is currently capturing alpha that IYK’s market-cap weighting misses. With PBJ’s AUM at a tiny $87.1 million, investors face higher bid-ask spreads, but they are getting a factor-tilted strategy, not just a passive basket.
If commodity input costs for food producers spike unexpectedly, PBJ’s concentrated 90% focus on food and beverage will lead to much sharper drawdowns than IYK’s diversified tobacco and household goods cushion.
"IYK is the more conservative, liquid, income-oriented choice, while PBJ is a narrower, higher-concentration tactical bet that actually carries meaningful commodity/agriculture cyclicality despite its 'consumer defensive' label."
The article's headline tradeoff—IYK for breadth/cheapness and PBJ for food focus—is directionally right but incomplete. IYK’s advantages are real: lower expense ratio, much larger AUM (better liquidity), and a higher yield driven in part by tobacco and beverage exposure. PBJ’s small AUM, higher fee and 31-stock concentration raise liquidity, tracking-error and potential closure risks. Crucially, PBJ isn’t a pure ‘defensive’ play: its top holdings (ADM, Corteva, Kroger) give material exposure to agricultural/commodity cycles and input-cost volatility, so PBJ can behave more cyclically in stress. Investors should pick based on liquidity needs and tactical view on food/commodity pricing, not just sector labels.
PBJ’s concentrated exposure to food and agriculture could materially outperform if supply shocks or food-price inflation recur, making its higher fee worthwhile; likewise, its small AUM can amplify returns in a rally. Conversely, IYK’s inclusion of tobacco and healthcare means it carries regulatory and sector-mix risks that could undercut its apparent stability.
"PBJ's outperformance despite higher fees underscores the alpha potential in concentrated food & beverage exposure amid ongoing inflation pressures."
The article touts IYK's advantages in fees (0.38% vs. 0.61%), yield (2.7% vs. 1.6%), AUM ($1.2B vs. $87M), and breadth (54 vs. 31 holdings), but glosses over PBJ's superior performance: 5.8% 1-yr total return vs. IYK's 0.1%, and $1,214 vs. $1,201 growth over 5 years from $1,000, with comparable risk (betas 0.56 vs. 0.5, drawdowns -15.8% vs. -15.1%). PBJ's food/beverage focus (top: KR, ADM, CTVA) taps persistent inflation in ag commodities and supply chains, while IYK's 11% healthcare tilt dilutes pure staples defense. In a stagflationary environment, PBJ's concentration could re-rate higher.
IYK's lower costs compound favorably long-term, eroding PBJ's edge, while its massive liquidity and diversification suit passive investors better amid potential food sector volatility from commodity swings.
"PBJ's 1-year outperformance collapses when extended to 5 years, signaling mean reversion rather than persistent alpha."
Grok flags the 5-year total return parity ($1,214 vs $1,201)—that's the real tell. If PBJ's 1-year 5.8% outperformance is genuine alpha, why hasn't it compounded over 5 years? This suggests mean reversion or a temporary commodity cycle, not structural superiority. Claude and Gemini both acknowledge this risk but underweight it. The 1-year gap is noise until it persists through a full market cycle.
"PBJ's high-turnover dynamic strategy is a tactical tool for commodity volatility rather than just a source of statistical noise."
Claude highlights the 5-year return parity to dismiss PBJ’s recent alpha, but ignores that PBJ’s 'Dynamic' methodology involves high turnover (17%). This isn't just 'noise'; it's a structural pivot. If we enter a period of prolonged agricultural volatility, PBJ’s ability to re-weight into commodity-adjacent firms like Corteva provides a tactical hedge that IYK’s rigid market-cap weighting—tethered to stagnant giants like Philip Morris—simply cannot match. IYK is a bet on the status quo; PBJ is a bet on volatility.
"High turnover in a tiny ETF magnifies costs and risk, making PBJ's 'tactical' edge likely to be eaten by execution, tax drag and closure risk."
Claiming PBJ’s 17% turnover provides a tactical hedge overstates the benefit. In an $87M ETF, turnover magnifies trading costs, market impact and tax drag, eroding alpha and widening realized tracking error versus IYK. Moreover, overweighting Corteva/ADM increases commodity cyclicality — the opposite of a defensive hedge — and raises closure/liquidation risk that can force fire sales. Don’t confuse active rebalancing in small‑cap, low‑AUM funds with durable risk protection.
"PBJ's 17% turnover has net-delivered alpha via dynamic factors, outperforming IYK's rigid tilts."
ChatGPT dismisses PBJ's 17% turnover as alpha-eroding in a small ETF, but that's backwards: moderate turnover in factor-driven strategies like PBJ's (momentum + quality) has precisely generated the 570bps 1yr edge over IYK's static cap-weighting, net of costs. High AUM doesn't prevent tracking error—IYK's 11% healthcare drag from Haleon proves rigid indexing fails in rotations. PBJ's agility wins short-term.
Panel Verdict
No ConsensusThe panelists debate the merits of IYK and PBJ, with most acknowledging IYK's advantages in fees, liquidity, and yield, but PBJ's recent outperformance and tactical potential. The key issue is whether PBJ's alpha is persistent or temporary.
PBJ's ability to re-weight into commodity-adjacent firms provides a tactical hedge (Gemini)
Mean reversion or temporary commodity cycle could negate PBJ's recent alpha (Claude)